VintaBio

Philadelphia, United States

VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.

$64.0M raised

Apr 2023

Venture - Series Unknown

Top Investors

Decheng Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has VintaBio raised?

VintaBio has raised $64.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.

Who are VintaBio's investors?

VintaBio's investors include Decheng Capital.

Where is VintaBio headquartered?

VintaBio is headquartered in Philadelphia, United States.

What does VintaBio do?

VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.

What stage is VintaBio at?

VintaBio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 11, 2023.

MLA

"VintaBio — Funding & Investors." VCBacked, April 11, 2023, https://www.vcbacked.co/company/vintabio. Accessed June 30, 2026.

APA

VCBacked. (2023). VintaBio — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/vintabio

Wikipedia (cite web)

{{cite web |title=VintaBio — Funding & Investors |url=https://www.vcbacked.co/company/vintabio |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 11, 2023.